Evidence map›Paper›PMID 31165419›Full record

ArticleCancer causes & control : CCC2019

Blood transfusion history and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis.

James R Cerhan, Eleanor Kane, Claire M Vajdic, Martha S Linet, Alain Monnereau, Leslie Bernstein, Silvia de Sanjose, Brian C-H Chiu, John J Spinelli, L Dal Maso and 11 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer causes & control : CCC, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Epidemiology of Follicular Lymphoma.Hematology/oncology clinics of North America · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 17 institutions in 7 countries.

James R CerhanDivision of Epidemiology, Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. cerhan.james@mayo.edu.ORCID http://orcid.org/0000-0002-7482-178X
Eleanor KaneEpidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, Heslington, York, YO10 5DD, UK.ORCID http://orcid.org/0000-0002-7438-9982
Claire M VajdicCentre for Big Data Research in Health, University of New South Wales, AGSM Building, Level 1 (G27), UNSW, Kensington, NSW, 2052, Australia.ORCID http://orcid.org/0000-0002-3612-8298
Martha S LinetDivision of Cancer Epidemiology and Genetics, National Cancer Institute, 9609 Medical Center Drive Room 7E452, Bethesda, MD, 20892-9778, USA.ORCID http://orcid.org/0000-0002-1687-5587
Alain MonnereauRegistre des Hémopathies Malignes de la Gironde, Institut Bergonié, University of Bordeaux, Inserm, Team EPICENE, UMR 1219, 33000, Paris, France.ORCID http://orcid.org/0000-0002-5056-1397
Leslie BernsteinDepartment of Population Sciences, Beckman Research Institute of City of Hope, 1500 E Duarte Rd, Duarte, CA, 91010, USA.ORCID http://orcid.org/0000-0002-7692-6518
Silvia de SanjoseCancer Epidemiology Research Programme, |IDIBELL | CIBERESP| Institut Català d'Oncologia, Barcelona, Spain.ORCID http://orcid.org/0000-0002-5909-676X
Brian C-H ChiuDepartment of Public Health Sciences, University of Chicago, 5841 S. Maryland Ave, MC 2000, Chicago, IL, 60637, USA.ORCID http://orcid.org/0000-0001-8979-7244
John J SpinelliSchool of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.ORCID http://orcid.org/0000-0002-9119-3287
L Dal MasoCancer Epidemiology Unit, Centro di Riferimento Oncologico IRCCS, Aviano, Italy.ORCID http://orcid.org/0000-0001-6163-200X
Yawei ZhangSection of Surgical Outcomes and Epidemiology, Department of Surgery, Yale School of Medicine, 60 College Street, New Haven, CT, 06520, USA.
Beth R LarrabeeDivision of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0001-9100-563X
Wendy CozenDepartments of Preventive Medicine and Pathology, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0003-3415-8247
Alexandra G SmithEpidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, Heslington, York, YO10 5DD, UK.ORCID http://orcid.org/0000-0002-1111-966X
Jacqueline ClavelEpidemiology of Childhood and Adolescent Cancers Group, Inserm, Center of Research in Epidemiology and Statistics Sorbonne Paris Cité (CRESS), Paris, France.ORCID http://orcid.org/0000-0002-3616-7676
Diego SerrainoCancer Epidemiology Unit, Centro di Riferimento Oncologico IRCCS, Aviano, Italy.ORCID http://orcid.org/0000-0003-0565-8920
Tongzhang ZhengDepartment of Epidemiology, Brown School of Public Health, Providence, RI, 02912, USA.
Elizabeth A HollyDept of Epidemiology and Biostatistics, University of California San Francisco, 3333 California Street, Suite 280, San Francisco, CA, 94118, USA.
Dennis D WeisenbergerDepartment of Pathology, City of Hope Medical Center, 1500 East Duarte Road, Duarte, CA, 91010, USA.
Susan L SlagerDivision of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0002-5173-4712
Paige M BracciDept of Epidemiology and Biostatistics, University of California San Francisco, 3333 California Street, Suite 280, San Francisco, CA, 94118, USA.ORCID http://orcid.org/0000-0001-9338-9307
Centro di Riferimento Oncologico · ITMayo Clinic in Florida · USUniversity of California, San Francisco · USUniversity of York · GBBrown University · USChicago Department of Public Health · USCity of Hope · USCity Of Hope National Medical Center · USDélégation Paris 5 · FRInstitut d'Investigació Biomédica de Bellvitge · ESMayo Clinic · USNational Cancer Institute · USUniversité de Bordeaux · FRUniversity of British Columbia · CAUniversity of Southern California · USUNSW Sydney · AUYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
The Role of Monocytes in non-Hodgkin LymphomaP50CA097274 · NCI · UNIVERSITY OF IOWA · PI WEINER, GEORGE J. · 2002 to 2021
$45.7M
Molecular Epidemiology of non Hodgkin's LymphomaR01CA087014 · NCI · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI HOLLY, ELIZABETH A. · 2001 to 2005
$6.7M
Molecular Epidemiology of NHL and CLLR01CA092153 · NCI · MAYO CLINIC ROCHESTER · PI CERHAN, JAMES R · 2003 to 2012
$6.7M
SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS--SEERN01PC065064 · PC · WAYNE STATE UNIVERSITY · PI WEISS, LINDA K · 1996 to 2000
$4.5M
SURVEILLANCE EPIDEMIOLOGY &END RESULTS PROGRAMN01PC067008 · PC · UNIVERSITY OF IOWA · PI LYNCH, CHARLES · 1996 to 2000
$3.8M
SURVEILLANCE EPIDEMIOLOGY &END RESULTS PROGRAMN01PC067009 · PC · FRED HUTCHINSON CANCER RESEARCH CENTER · PI THOMAS, DAVID B · 1996 to 2000
$3.0M
SURVEILLANCE EPIDEMIOLOGY &END RESULTS PROGRAMN01PC067010 · PC · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ROSS, RONALD K · 1996 to 2000
$2.4M
Cooperative Mechanisms in IL-4-Induced Gene ExpressionR01AI050850 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI BERTON, MICHAEL T · 2003 to 2007
$1.6M
Lymphoma Defined Cytogenetically for Epidemiologic StudyR01CA100555 · NCI · UNIVERSITY OF CHICAGO · PI CHIU, BRIAN C-H · 2005 to 2009
$1.0M
Robust rank-based methods and detection of GXE in cancer etiology and survivalR21CA165923 · NCI · YALE UNIVERSITY · PI MA, SHUANGGE, ZHANG, YAWEI · 2012 to 2014
$421k
EPIDEMIOLOGY OF NON HODGKINS'S LYMPHOMA DATA ANALYSISR03CA089745 · NCI · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI HOLLY, ELIZABETH A. · 2001 to 2002
$148k
NCATS NIH HHS UL1 TR001863NCI NIH HHS N01 CO012400NCI NIH HHS N01 PC065064NCI NIH HHS N01 PC067008NCI NIH HHS N01 PC067009NCI NIH HHS N01 PC067010NCI NIH HHS P50 CA097274NCI NIH HHS R01 CA045614NCI NIH HHS R01 CA062006NCI NIH HHS R01 CA087014NCI NIH HHS R01 CA092153NCI NIH HHS R01 CA100555NCI NIH HHS R03 CA089745NCI NIH HHS R21 CA165923NIAID NIH HHS R01 AI050850
6 · The paper itself

Abstract

purposeTo conduct a pooled analysis assessing the association of blood transfusion with risk of non-Hodgkin lymphoma (NHL).

methodsWe used harmonized data from 13 case-control studies (10,805 cases, 14,026 controls) in the InterLymph Consortium. Odds ratios (OR) and 95% confidence intervals (CI) were calculated using unconditional logistic regression, adjusted for study design variables.

resultsAmong non-Hispanic whites (NHW), history of any transfusion was inversely associated with NHL risk for men (OR 0.74; 95% CI 0.65-0.83) but not women (OR 0.92; 95% CI 0.83-1.03), p

conclusionsIn the setting of a literature reporting mainly null and some positive associations, and the lack of a clear methodologic explanation for our inverse association restricted to NHW men, the current body of evidence suggests that there is no association of blood transfusion with risk of NHL.

Indexed as

Blood TransfusionAdolescentAdultAgedAged, 80 and overCase-Control StudiesFemaleHumansLogistic ModelsLymphoma, Non-HodgkinMaleMiddle AgedOdds RatioRisk FactorsYoung AdultEpidemiologyEtiologyLymphomaPooled analysisTransfusion

Identifiers

PMID31165419
PMCPMC6613988
OpenAlexW2948592421

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.